It is a trading private limited company based in Nagpur, Maharashtra, India, established in 2014.
2014 | Nagpur, Maharashtra, India | ActiveMendbrisk Pharmaceuticals Private Limited, a active private limited company, was established on 05 December 2014 in Nagpur, Maharashtra, India. Engaging in wholesale within the trade sector, it holds CIN: U24100MH2014PTC259997. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Dhirendra Dinakar Kukde (Director), Amit Turrey (Director). Past directors included Dhirendra Dinakar Kukde, Atish Laxman Pardikar. It holds ₹0.70 M open charges and no settled loans. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at Plot No. 6011/M/36 Sakkardara, Bank Colony, Durga Nagar, Nagpur, Maharashtra, 440024.
U24100MH2014PTC259997
259997
05 December 2014
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Mendbrisk Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dhirendra Dinakar Kukde | Director | 11 Jul 2018 | Current |
| Amit Turrey | Director | 05 Dec 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 14 Jan 2016 | Past |
| Pramod Abcsdd | Director | 11 Jul 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Mendbrisk Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 84.07% decrease. The company also saw a substantial fall in profitability, with a 76.89% decrease in profit. The company's net worth Soared by an impressive increase of 15.94%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Mendbrisk Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹700,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Mar 2019 | Others | ₹0.70 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Mendbrisk Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Mendbrisk Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mendbrisk Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Mendbrisk Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was recorded as a recent event.
Mendbrisk Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Mumbai. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 0.70 M with Charge ID 100255384 was registered on 15 Mar 2019. was documented.
Progress on Dhirendra Dinakar Kukde was appointed as a Director was appointed as a Director on 11 Jul 2018 & has been associated with this company since 7 years 5 months . was documented.
Progress on Amit Turrey was appointed as a Director was appointed as a Director on 05 Dec 2014 & has been associated with this company since 11 years 18 days . was documented.
Mendbrisk Pharmaceuticals Private Limited was registered on 05 Dec 2014 with Roc Mumbai & aged 11 years 18 days as per MCA records. was recorded as a recent event.
The CIN of Mendbrisk Pharmaceuticals Private Limited is U24100MH2014PTC259997.
Mendbrisk Pharmaceuticals Private Limited is headquartered at Plot No. 6011/M/36 Sakkardara, Bank Colony, Durga Nagar, Nagpur, Maharashtra, 440024.
Mendbrisk Pharmaceuticals Private Limited was incorporated on 05 December 2014.
The current directors of Mendbrisk Pharmaceuticals Private Limited are
The primary industry of Mendbrisk Pharmaceuticals Private Limited is Trade.
Mendbrisk Pharmaceuticals Private Limited is unlisted.
The authorized capital of Mendbrisk Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Mendbrisk Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX